Allogene Therapeutics, Inc. · NASDAQ:ALLO

Lynx1 Capital Management LP's stake in Allogene Therapeutics, Inc. fell below 5% (Schedule 13G/A)

Event Dec 31, 2025 · Filed May 15, 2026

Lynx1 Capital Management LP's stake in Allogene Therapeutics, Inc. fell below 5%, 0 shares, as a passive investor on Dec 31, 2025. Filed May 15, 2026 (Schedule 13G/A).

Stake
0%
Shares
0
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Lynx1 Capital Management LP0%0
Weston Nichols0%0

Source

View original at SEC

Related